Chief Executive Officer (CEO) of PVUNL, R K Singh on Friday said that the year 2025 would be a year of development and ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza ... COVID-19 and flu in a single jab in a phase 1/2 trial, while a triple shot that also adds in ...

J&J, meanwhile, also reported topline results from another phase 3 trial called ICONIC-TOTAL that it said showed icotrokinra met the primary endpoint of an IGA score of 0/1 at week 16 compared to ...

Janux Therapeutics has a robust balance sheet, with $658.1 million in liquid assets and no debt. See why I reiterate my buy ...

The Plug Power stock price has crawled back after plunging to a low of $1.61 in September last year. It bounced back to a ...

(TSX: IVN) has released its production results for 2024 across its assets in the Democratic Republic of the Congo, along with ...

The pre-construction process is set to start this week for the rebuild of the Francis Scott Key Bridge, which Maryland ...

The single biggest safety threat in 2025 is probably the risk of an incident, and resulting pollution, from the poorly ...

Elon Musk's xAI supercomputer in Memphis was up and running in September. Here's a look at the project's progress and what's ...

Follow The Hindu’s LIVE updates as Election Commission of India announces poll schedule for the Delhi Assembly elections ...

SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company”) announced today that its SomaScan™ Platform played a pivotal role in a study ...

NDAQ:KMDA) Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025 ...